002728 特一药业
交易中 08-16 14:17:42
资讯
新帖
简况
特一药业(002728)8月15日主力资金净卖出2203.75万元
证券之星 · 08-15 15:21
特一药业(002728)8月15日主力资金净卖出2203.75万元
【创新药概念股爆发,广生堂20CM涨停 最新回应来了】金十数据8月12日讯,创新药概念今日持续走高,广生堂20CM涨停,以岭药业、特一药业涨停,多只个股跟涨。
美港电讯 · 08-12
【创新药概念股爆发,广生堂20CM涨停 最新回应来了】金十数据8月12日讯,创新药概念今日持续走高,广生堂20CM涨停,以岭药业、特一药业涨停,多只个股跟涨。
8月12日特一药业涨停分析:新冠药物,长寿药NMN,中药概念热股
证券之星 · 08-12
8月12日特一药业涨停分析:新冠药物,长寿药NMN,中药概念热股
特一药业(002728)8月12日主力资金净买入8485.56万元
证券之星 · 08-12
特一药业(002728)8月12日主力资金净买入8485.56万元
异动快报:特一药业(002728)8月12日9点44分触及涨停板
证券之星 · 08-12
异动快报:特一药业(002728)8月12日9点44分触及涨停板
特一药业(002728)8月9日主力资金净卖出448.00万元
证券之星 · 08-09
特一药业(002728)8月9日主力资金净卖出448.00万元
特一药业:目前,公司根据市场需求并结合营销组织变革步伐合理安排止咳宝片生产及销售
证券之星 · 08-08
特一药业:目前,公司根据市场需求并结合营销组织变革步伐合理安排止咳宝片生产及销售
特一药业:皮肤病血毒丸、降糖舒丸市场反馈情况较好特一药业接受媒体采访时表示,止咳宝片产品对公司的经营业绩能产生较大的影响,但并未形成过度依赖。
格隆汇 · 08-05
特一药业:皮肤病血毒丸、降糖舒丸市场反馈情况较好特一药业接受媒体采访时表示,止咳宝片产品对公司的经营业绩能产生较大的影响,但并未形成过度依赖。
特一药业:8月5日接受媒体采访,华夏时报参与
证券之星 · 08-05
特一药业:8月5日接受媒体采访,华夏时报参与
特一药业(002728.SZ)已累计回购2.25%股份 耗资约8506万元
智通财经 · 08-01
特一药业(002728.SZ)已累计回购2.25%股份 耗资约8506万元
特一药业(002728)2024年中报简析:净利润减98.23%,三费占比上升明显
证券之星 · 07-27
特一药业(002728)2024年中报简析:净利润减98.23%,三费占比上升明显
特一药业半年度盈利由1.5亿跌至60万 营销组织改革背后或有库存积压隐忧
新浪证券 · 07-26
特一药业半年度盈利由1.5亿跌至60万 营销组织改革背后或有库存积压隐忧
特一药业(002728)7月26日主力资金净卖出333.99万元
证券之星 · 07-26
特一药业(002728)7月26日主力资金净卖出333.99万元
图解特一药业中报:第二季度单季净利润同比减113.86%
证券之星 · 07-26
图解特一药业中报:第二季度单季净利润同比减113.86%
特一药业公布半年报 上半年净利减少98.23%
智能小浪 · 07-25
特一药业公布半年报 上半年净利减少98.23%
特一药业(002728.SZ)发布上半年业绩,净利润268.94万元,下降98.23%
智通财经 · 07-25
特一药业(002728.SZ)发布上半年业绩,净利润268.94万元,下降98.23%
【特一药业(002728.SZ)发布上半年业绩,净利润268.94万元,下降98.23%】智通财经APP讯,特一药业(002728.
智通财经 · 07-25
【特一药业(002728.SZ)发布上半年业绩,净利润268.94万元,下降98.23%】智通财经APP讯,特一药业(002728.
特一药业最新公告:半年度净利润同比下降98.23%
证券之星 · 07-25
特一药业最新公告:半年度净利润同比下降98.23%
特一药业最新公告:2024年半年度报告披露日期变更为7月26日
证券之星 · 07-18
特一药业最新公告:2024年半年度报告披露日期变更为7月26日
特一药业:延期至7月26日披露2024年半年度报告特一药业公告,原计划于2024年7月19日披露《2024年半年度报告》。
格隆汇 · 07-18
特一药业:延期至7月26日披露2024年半年度报告特一药业公告,原计划于2024年7月19日披露《2024年半年度报告》。
加载更多
公司概况
公司名称:
特一药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2014-07-31
主营业务:
特一药业集团股份有限公司的主营业务是中成药品、化学制剂药品、化学原料药的研发、生产和销售。公司的主要产品包括止咳宝片、罗红霉素胶囊、阿莫西林胶囊、血塞通分散片、铝碳酸镁咀嚼片、皮肤病血毒丸、金匮肾气片等。此外,公司生产的止咳宝片、金匮肾气片、红霉素肠溶片和依托红霉素片等27个药品被广东省科学技术厅认定为“广东省高新技术产品”。公司的特一品牌被广东省工商行政管理局认定为“广东省著名商标”,特一品牌亦被广东省医药行业协会评为“广东省中成药、中药饮片行业领军品牌”。
发行价格:
14.00
{"stockData":{"symbol":"002728","market":"SZ","secType":"STK","nameCN":"特一药业","latestPrice":8.36,"timestamp":1723789062000,"preClose":8.54,"halted":0,"volume":22475976,"delay":0,"floatShares":375000000,"shares":511000000,"eps":0.2032,"marketStatus":"交易中","marketStatusCode":2,"change":-0.18,"latestTime":"08-16 14:17:42","open":8.45,"high":8.49,"low":8.25,"amount":188000000,"amplitude":0.0281,"askPrice":8.37,"askSize":97,"bidPrice":8.36,"bidSize":418,"shortable":0,"etf":0,"ttmEps":0.2032,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1723791600000},"adr":0,"adjPreClose":8.54,"symbolType":"stock","openAndCloseTimeList":[[1723771800000,1723779000000],[1723784400000,1723791600000]],"highLimit":9.39,"lowLimit":7.69,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":510693274,"pbRate":2.39,"roa":"--","roe":"0.14%","epsLYR":0.77,"committee":0.278696,"marketValue":4269000000,"floatMarketCap":3131000000,"peRate":41.141733,"changeRate":-0.0211,"turnoverRate":0.06,"status":1},"requestUrl":"/m/hq/s/002728","defaultTab":"news","newsList":[{"id":"2459415623","title":"特一药业(002728)8月15日主力资金净卖出2203.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459415623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459415623?lang=zh_cn&edition=full","pubTime":"2024-08-15 15:21","pubTimestamp":1723706506,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月15日收盘,特一药业报收于8.54元,下跌2.95%,换手率9.41%,成交量35.25万手,成交额3.02亿元。8月15日的资金流向数据方面,主力资金净流出2203.75万元,占总成交额7.29%,游资资金净流入179.23万元,占总成交额0.59%,散户资金净流入2024.52万元,占总成交额6.7%。特一药业主营业务:中成药品、化学制剂药品、化学原料药的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500025565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002728","BK0201"],"gpt_icon":0},{"id":"2458675070","title":"【创新药概念股爆发,广生堂20CM涨停 最新回应来了】金十数据8月12日讯,创新药概念今日持续走高,广生堂20CM涨停,以岭药业、特一药业涨停,多只个股跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2458675070","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458675070?lang=zh_cn&edition=full","pubTime":"2024-08-12 16:26","pubTimestamp":1723451177,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["002728","06978","BK1161","BK0201","BK0239","BK0097","159992","BK0188","BK0042","002603","BK0046","300436","BK1574"],"gpt_icon":0},{"id":"2458620041","title":"8月12日特一药业涨停分析:新冠药物,长寿药NMN,中药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2458620041","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458620041?lang=zh_cn&edition=full","pubTime":"2024-08-12 15:31","pubTimestamp":1723447896,"startTime":"0","endTime":"0","summary":"证券之星消息,特一药业8月12日涨停收盘,收盘价8.55元。该股于9点44分涨停,2次打开涨停,截止收盘封单资金为4753.82万元,占其流通市值1.48%。8月12日的资金流向数据方面,主力资金净流入8485.56万元,占总成交额39.77%,游资资金净流出3600.42万元,占总成交额16.87%,散户资金净流出4885.14万元,占总成交额22.9%。近5日资金流向一览见下表:该股为新冠药物,长寿药NMN,中药概念热股,当日新冠药物概念上涨3.32%,长寿药NMN概念上涨2.86%,中药概念上涨2.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200014080.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002728","BK0239"],"gpt_icon":0},{"id":"2458620839","title":"特一药业(002728)8月12日主力资金净买入8485.56万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458620839","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458620839?lang=zh_cn&edition=full","pubTime":"2024-08-12 15:18","pubTimestamp":1723447081,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月12日收盘,特一药业报收于8.55元,上涨10.04%,涨停,换手率6.77%,成交量25.36万手,成交额2.13亿元。8月12日的资金流向数据方面,主力资金净流入8485.56万元,占总成交额39.77%,游资资金净流出3600.42万元,占总成交额16.87%,散户资金净流出4885.14万元,占总成交额22.9%。特一药业主营业务:中成药品、化学制剂药品、化学原料药的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200013114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002728"],"gpt_icon":0},{"id":"2458645773","title":"异动快报:特一药业(002728)8月12日9点44分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2458645773","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458645773?lang=zh_cn&edition=full","pubTime":"2024-08-12 09:45","pubTimestamp":1723427153,"startTime":"0","endTime":"0","summary":"证券之星8月12日盘中消息,9点44分特一药业触及涨停板。目前价格8.49,上涨9.27%。其所属行业中药目前上涨。领涨股为香雪制药。该股为中药,化学原料药,医药概念热股,当日中药概念上涨0.98%,化学原料药概念上涨0.87%,医药概念上涨0.79%。8月9日的资金流向数据方面,主力资金净流出448.0万元,占总成交额6.16%,游资资金净流出927.75万元,占总成交额12.76%,散户资金净流入1375.75万元,占总成交额18.92%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200003852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0239","BK0201"],"gpt_icon":0},{"id":"2458796532","title":"特一药业(002728)8月9日主力资金净卖出448.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458796532","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458796532?lang=zh_cn&edition=full","pubTime":"2024-08-09 15:26","pubTimestamp":1723188416,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月9日收盘,特一药业报收于7.77元,下跌2.75%,换手率2.47%,成交量9.25万手,成交额7271.75万元。8月9日的资金流向数据方面,主力资金净流出448.0万元,占总成交额6.16%,游资资金净流出927.75万元,占总成交额12.76%,散户资金净流入1375.75万元,占总成交额18.92%。特一药业主营业务:中成药品、化学制剂药品、化学原料药的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080900025913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002728"],"gpt_icon":0},{"id":"2457369795","title":"特一药业:目前,公司根据市场需求并结合营销组织变革步伐合理安排止咳宝片生产及销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2457369795","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457369795?lang=zh_cn&edition=full","pubTime":"2024-08-08 17:02","pubTimestamp":1723107774,"startTime":"0","endTime":"0","summary":"证券之星消息,特一药业(002728)08月08日在投资者关系平台上答复投资者关心的问题。投资者:尊敬的董秘,请问止咳宝目前的生产情况如何?特一药业董秘:您好,感谢您对公司的关注。目前,公司根据市场需求并结合营销组织变革步伐合理安排止咳宝片生产及销售。谢谢!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800033827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","002728"],"gpt_icon":0},{"id":"2457776334","title":"特一药业:皮肤病血毒丸、降糖舒丸市场反馈情况较好特一药业接受媒体采访时表示,止咳宝片产品对公司的经营业绩能产生较大的影响,但并未形成过度依赖。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457776334","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457776334?lang=zh_cn&edition=full","pubTime":"2024-08-05 22:04","pubTimestamp":1722866647,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0201","BK0239","002728"],"gpt_icon":0},{"id":"2457720891","title":"特一药业:8月5日接受媒体采访,华夏时报参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2457720891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457720891?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:21","pubTimestamp":1722864102,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年8月5日特一药业发布公告称公司于2024年8月5日接受媒体采访,华夏时报于娜 陈岩鹏参与。止咳宝片产品对公司的经营业绩能产生较大的影响,但并未形成过度依赖。在国家产业政策大力支持中医药行业发展的背景下,鉴于皮肤病血毒丸、降糖舒丸的市场潜力较大,公司已将上述品种作为继止咳宝片后的重大品种进行培育。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080500032589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002728","BK0239"],"gpt_icon":0},{"id":"2456177596","title":"特一药业(002728.SZ)已累计回购2.25%股份 耗资约8506万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456177596","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456177596?lang=zh_cn&edition=full","pubTime":"2024-08-01 16:58","pubTimestamp":1722502707,"startTime":"0","endTime":"0","summary":"智通财经APP讯,特一药业(002728.SZ)发布公告,截至2024年7月31日,公司通过深圳证券交易所交易系统以集中竞价交易方式购回公司股份1151.46万股,占公司目前总股本的比例为2.25%,回购成交的最高价为8.03元/股,最低价为7.07元/股,支付的资金总额为人民币8506万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1158732.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0201","BK0239","002728"],"gpt_icon":0},{"id":"2454610309","title":"特一药业(002728)2024年中报简析:净利润减98.23%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2454610309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454610309?lang=zh_cn&edition=full","pubTime":"2024-07-27 06:05","pubTimestamp":1722031546,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期特一药业发布2024年中报。根据财报显示,本报告期中特一药业净利润减98.23%,三费占比上升明显。截至本报告期末,公司营业总收入3.14亿元,同比下降41.72%,归母净利润268.94万元,同比下降98.23%。答:2024 年第一季度,公司实现营业收入 1.65 亿元,同比下降 45.88%;归属于上市公司股东的净利润 915.46 万元,同比下降 91.32%的经营业绩。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072700010777.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728"],"gpt_icon":0},{"id":"2454027313","title":"特一药业半年度盈利由1.5亿跌至60万 营销组织改革背后或有库存积压隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2454027313","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454027313?lang=zh_cn&edition=full","pubTime":"2024-07-26 17:24","pubTimestamp":1721985840,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 7月25日晚间,特一药业发布半年度业绩报告。因此,特一药业营销组织改革,大幅减少供货的背后或也有市场库存较高抑制经销商拿货意愿的因素。 股价方面,截止今日收盘,特一药业收跌2.05%,报收7.17元/股,与2023年末的17.13元/股高点相比股价已接近膝盖斩,目前公司总市值为36.6亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/observe/2024-07-26/doc-incfneiw5167866.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2024-07-26/doc-incfneiw5167866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002728","BK0239","BK0201"],"gpt_icon":0},{"id":"2454965433","title":"特一药业(002728)7月26日主力资金净卖出333.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454965433","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454965433?lang=zh_cn&edition=full","pubTime":"2024-07-26 15:22","pubTimestamp":1721978542,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月26日收盘,特一药业报收于7.17元,下跌2.05%,换手率3.39%,成交量12.72万手,成交额9125.24万元。7月26日的资金流向数据方面,主力资金净流出333.99万元,占总成交额3.66%,游资资金净流入216.49万元,占总成交额2.37%,散户资金净流入117.5万元,占总成交额1.29%。特一药业主营业务:中成药品、化学制剂药品、化学原料药的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072600025449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0239","BK0201"],"gpt_icon":0},{"id":"2454071518","title":"图解特一药业中报:第二季度单季净利润同比减113.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454071518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454071518?lang=zh_cn&edition=full","pubTime":"2024-07-26 01:26","pubTimestamp":1721928413,"startTime":"0","endTime":"0","summary":"证券之星消息,特一药业2024年中报显示,公司主营收入3.14亿元,同比下降41.72%;归母净利润268.94万元,同比下降98.23%;扣非净利润61.47万元,同比下降99.59%;其中2024年第二季度,公司单季度主营收入1.49亿元,同比下降36.33%;单季度归母净利润-646.52万元,同比下降113.86%;单季度扣非净利润-830.99万元,同比下降118.31%;负债率24.08%,投资收益104.65万元,财务费用-54.68万元,毛利率39.55%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072600001816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728"],"gpt_icon":0},{"id":"2454823700","title":"特一药业公布半年报 上半年净利减少98.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454823700","media":"智能小浪","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454823700?lang=zh_cn&edition=full","pubTime":"2024-07-25 18:40","pubTimestamp":1721904000,"startTime":"0","endTime":"0","summary":" 7月25日消息,特一药业发布半年度报告。 公告显示,公司半年度营业收入313,748,456.95元,同比减少41.72%,归属上市公司股东的净利润2,689,430.91元,同比减少98.23%。 公告显示,十大流通股东中,招商银行股份有限公司-兴全中证800六个月持有期指数增强型证券投资基金、中国农业银行股份有限公司-兴全沪深300指数增强型证券投资基金、邱淦清、阮传明、东海基金-郑如恒-东海基金-金龙141号单一资产管理计划为新进流通股东。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-07-25/doc-incfizkw6081447.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-07-25/doc-incfizkw6081447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0201","002728"],"gpt_icon":0},{"id":"2454584265","title":"特一药业(002728.SZ)发布上半年业绩,净利润268.94万元,下降98.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454584265","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454584265?lang=zh_cn&edition=full","pubTime":"2024-07-25 17:31","pubTimestamp":1721899909,"startTime":"0","endTime":"0","summary":"智通财经APP讯,特一药业(002728.SZ)发布2024年半年度报告,该公司营业收入为3.14亿元,同比减少41.72%。归属于上市公司股东的净利润为268.94万元,同比减少98.23%。归属于上市公司股东的扣除非经常性损益的净利润为61.47万元,同比减少99.59%。基本每股收益为0.005元。由于公司减少了止咳宝片的发货,以及对品牌的持续投入,导致了公司2024年半年度业绩下降幅度较大。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1155589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002728"],"gpt_icon":0},{"id":"2454426158","title":"【特一药业(002728.SZ)发布上半年业绩,净利润268.94万元,下降98.23%】智通财经APP讯,特一药业(002728.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454426158","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454426158?lang=zh_cn&edition=full","pubTime":"2024-07-25 17:31","pubTimestamp":1721899909,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0239","BK0201","002728"],"gpt_icon":0},{"id":"2454184258","title":"特一药业最新公告:半年度净利润同比下降98.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454184258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454184258?lang=zh_cn&edition=full","pubTime":"2024-07-25 17:30","pubTimestamp":1721899802,"startTime":"0","endTime":"0","summary":"特一药业披露2024年半年度报告,报告期内,公司实现营业收入3.14亿元,同比下降41.72%;归属于上市公司股东的净利润268.94万元,同比下降98.23%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500037046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728"],"gpt_icon":0},{"id":"2452477103","title":"特一药业最新公告:2024年半年度报告披露日期变更为7月26日","url":"https://stock-news.laohu8.com/highlight/detail?id=2452477103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452477103?lang=zh_cn&edition=full","pubTime":"2024-07-18 17:49","pubTimestamp":1721296178,"startTime":"0","endTime":"0","summary":"特一药业公告,公司原计划于2024年7月19日披露《2024年半年度报告》。现根据公司半年度报告编制工作进展情况,为确保公司定期报告披露的真实性、准确性、完整性,经向深圳证券交易所申请,公司《2024年半年度报告》披露日期变更为2024年7月26日。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071800037348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002728","BK0239"],"gpt_icon":0},{"id":"2452108246","title":"特一药业:延期至7月26日披露2024年半年度报告特一药业公告,原计划于2024年7月19日披露《2024年半年度报告》。","url":"https://stock-news.laohu8.com/highlight/detail?id=2452108246","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452108246?lang=zh_cn&edition=full","pubTime":"2024-07-18 17:44","pubTimestamp":1721295897,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0201","BK0239","399001","002728"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2014-07-31","address":"广东省江门市台山市台城长兴路9、11号","stockEarnings":[{"period":"1week","weight":0.0688},{"period":"1month","weight":0.1372},{"period":"3month","weight":-0.1039},{"period":"6month","weight":-0.0833},{"period":"1year","weight":-0.2489},{"period":"ytd","weight":-0.3084}],"companyName":"特一药业集团股份有限公司","boardCode":"AI0027","perCapita":"5378股","boardName":"医药制造业","registeredCapital":"51069万元","compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0332},{"period":"3month","weight":-0.0877},{"period":"6month","weight":0.004},{"period":"1year","weight":-0.0866},{"period":"ytd","weight":-0.0328}],"survey":" 特一药业集团股份有限公司的主营业务是中成药品、化学制剂药品、化学原料药的研发、生产和销售。公司的主要产品包括止咳宝片、罗红霉素胶囊、阿莫西林胶囊、血塞通分散片、铝碳酸镁咀嚼片、皮肤病血毒丸、金匮肾气片等。此外,公司生产的止咳宝片、金匮肾气片、红霉素肠溶片和依托红霉素片等27个药品被广东省科学技术厅认定为“广东省高新技术产品”。公司的特一品牌被广东省工商行政管理局认定为“广东省著名商标”,特一品牌亦被广东省医药行业协会评为“广东省中成药、中药饮片行业领军品牌”。","serverTime":1723789065219,"listedPrice":14,"stockholders":"69640人(较上一季度减少4.27%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供特一药业(002728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"特一药业,002728,特一药业股票,特一药业股票老虎,特一药业股票老虎国际,特一药业行情,特一药业股票行情,特一药业股价,特一药业股市,特一药业股票价格,特一药业股票交易,特一药业股票购买,特一药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供特一药业(002728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}